Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts-Reference-Cited by-同舟云学术

Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts

Published:2018-08-29 Issue:1 Volume:20 Page:
ISSN:1478-6362
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Raschi Elena,Chighizola Cecilia Beatrice^ORCID,Cesana Laura,Privitera Daniela,Ingegnoli Francesca,Mastaglio Claudio,Meroni Pier Luigi,Borghi Maria Orietta

Funder

IRCCS Istituto Auxologico Italiano

University of Milan, Department of Clinical Sciences and Community Health

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13075-018-1689-6.pdf

Reference53 articles.

1. Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390:1685–99.

2. Mehra S, Walker J, Patterson K, Fritzler MJ. Autoantibodies in systemic sclerosis. Autoimmun Rev. 2013;12:350–4.

3. Kayser C, Fritzler MJ. Autoantibodies in systemic sclerosis: unanswered questions. Front Immunol. 2015;6:167.

4. Nihtyanova SI, Denton CP. Autoantibodies as predictive tools in systemic sclerosis. Nat Rev Rheumatol. 2010;6:112–6.

5. Valentini G, Marcoccia A, Cuomo G, Vettori S, Iudici M, Bondanini F, et al. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity. Arthritis Care Res. 2014;66:1520–7.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenic role of anti‐nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseases;Immunological Reviews;2024-09-09

2. Anti-Th/To Antibodies in Scleroderma: Good Prognosis or Serious Concern?;Journal of Clinical Medicine;2024-05-21

3. Les anticorps antinucléaires : spectateurs ou acteurs ? Exemple de la sclérodermie systémique;Revue Francophone des Laboratoires;2024-05

4. Efferocytosis: Current status and future prospects in the treatment of autoimmune diseases;Heliyon;2024-04

5. Modulation of plasmacytoid dendritic cells response in inflammation and autoimmunity;Immunological Reviews;2024-03-29